111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.07%
Margin decline while JHX shows 6.87% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
160.27%
D&A growth above 1.5x JHX's 5.35%. Michael Burry would check for excessive investment.
-28.68%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
-0.22%
EBITDA margin decline while JHX shows 7.77% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
0.28%
Operating margin growth below 50% of JHX's 11.58%. Michael Burry would check for structural issues.
72.68%
Other expenses growth above 1.5x JHX's 30.77%. Michael Burry would check for concerning trends.
No Data
No Data available this quarter, please select a different quarter.
0.38%
Pre-tax margin growth while JHX declines. John Neff would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.28%
Net margin growth while JHX declines. John Neff would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
-1.44%
Both companies show declining diluted EPS. Martin Whitman would check industry conditions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.